Hicks RJ - Search Results

1

High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications.

Aide N, Desmonts C, Beauregard JM, Beyer T, Kinross K, Roselt P, Neels O, Agostini D, Bardet S, Bouvard G, Hicks RJ. Aide N, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2010 May;37(5):991-1001. doi: 10.1007/s00259-009-1352-1. Epub 2010 Jan 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20107792

2

Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.

Kalff V, Hicks RJ, Ware RE, Greer B, Binns DS, Hogg A. Kalff V, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):506-15. doi: 10.1007/s00259-001-0735-8. Epub 2002 Feb 15. Eur J Nucl Med Mol Imaging. 2002. PMID: 11914889

3

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent.

Hicks RJ, Rischin D, Fisher R, Binns D, Scott AM, Peters LJ. Hicks RJ, et al. Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1384-91. doi: 10.1007/s00259-005-1880-2. Epub 2005 Aug 26. Eur J Nucl Med Mol Imaging. 2005. PMID: 16133382 Clinical Trial.

4

Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging.

Solomon B, Binns D, Roselt P, Weibe LI, McArthur GA, Cullinane C, Hicks RJ. Solomon B, et al. Among authors: hicks rj. Mol Cancer Ther. 2005 Sep;4(9):1417-22. doi: 10.1158/1535-7163.MCT-05-0066. Mol Cancer Ther. 2005. PMID: 16170034

5

Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.

Dorow DS, Cullinane C, Conus N, Roselt P, Binns D, McCarthy TJ, McArthur GA, Hicks RJ. Dorow DS, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):441-52. doi: 10.1007/s00259-005-0039-5. Epub 2006 Feb 1. Eur J Nucl Med Mol Imaging. 2006. PMID: 16450138

6

Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer.

Duong CP, Demitriou H, Weih L, Thompson A, Williams D, Thomas RJ, Hicks RJ. Duong CP, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):759-69. doi: 10.1007/s00259-005-0028-8. Epub 2006 Feb 10. Eur J Nucl Med Mol Imaging. 2006. PMID: 16470369 Clinical Trial.

7

FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.

Duong CP, Hicks RJ, Weih L, Drummond E, Leong T, Michael M, Thomas RJ. Duong CP, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):770-8. doi: 10.1007/s00259-005-0040-z. Epub 2006 Mar 21. Eur J Nucl Med Mol Imaging. 2006. PMID: 16550384 Clinical Trial.

8

PET tracer development--a tale of mice and men.

Hicks RJ, Dorow D, Roselt P. Hicks RJ, et al. Cancer Imaging. 2006 Oct 31;6(Spec No A):S102-6. doi: 10.1102/1470-7330.2006.9098. Cancer Imaging. 2006. PMID: 17114061 Free PMC article.

9

Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

Reischl G, Dorow DS, Cullinane C, Katsifis A, Roselt P, Binns D, Hicks RJ. Reischl G, et al. Among authors: hicks rj. J Pharm Pharm Sci. 2007;10(2):203-11. J Pharm Pharm Sci. 2007. PMID: 17706178 Free article.

10

PET/MRI: a different spin from under the rim.

Hicks RJ, Lau EW. Hicks RJ, et al. Eur J Nucl Med Mol Imaging. 2009 Mar;36 Suppl 1:S10-4. doi: 10.1007/s00259-008-0966-z. Eur J Nucl Med Mol Imaging. 2009. PMID: 19104800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters